Stat5 is indispensable for the maintenance of bcr/abl ‐positive leukaemia-Reference-Cited by-同舟云学术

Stat5 is indispensable for the maintenance of bcr/abl ‐positive leukaemia

Published:2010-03 Issue:3 Volume:2 Page:98-110
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Hoelbl Andrea¹,Schuster Christian¹²,Kovacic Boris³,Zhu Bingmei⁴,Wickre Mark⁴,Hoelzl Maria A.¹,Fajmann Sabine¹,Grebien Florian⁵⁶,Warsch Wolfgang¹,Stengl Gabriele³,Hennighausen Lothar⁴,Poli Valeria⁷,Beug Hartmut³,Moriggl Richard⁸,Sexl Veronika¹

Affiliation:

1. Institute of Pharmacology, Centre of Biomolecular Medicine and Pharmacology, Medical University of Vienna (MUV), Vienna, Austria

2. Deutsches Krebsforschungszentrum (DKFZ), Heidelberg 69120, Germany

3. Research Institute of Molecular Pathology (IMP), Vienna, Austria

4. National Institute of Health (NIH), Bethesda, Maryland, USA

5. Max F. Perutz Laboratories (MFPL), MUV, Vienna, Austria

6. Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna 1090, Austria

7. Molecular Biotechnology Center, University of Turin, Turin, Italy

8. Ludwig Boltzmann Institute for Cancer Research (LBI‐CR), Vienna, Austria

Publisher

EMBO

Subject